Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
GOSS compared with INAB: revenue, margins and what each company keeps, and the suppliers and customers both name
GOSS
Gossamer Bio, Inc.
Change
Mkt cap
Revenue
Revenue
INAB
IN8BIO, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
GOSS
Gossamer Bio, Inc.
vs
INAB
IN8BIO, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Supply-chain overlap
Desk
News
Calendar
Saved
Search
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only GOSS
3
—
Chiesi
unlisted
customer
—
Pulmokine
unlisted
supplier
—
Respira Therapeutics
unlisted
supplier
Shared
0
No disclosed counterparties: INAB.
Only INAB
0
None
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
GOSS
Gossamer Bio, Inc.
Change
10.35
· pre 10.21
Mkt cap
$63.4M
Revenue
$9M
Q2 FY26
Revenue
$48M
FY25
INAB
IN8BIO, Inc.
Change
0.94
· pre 0.94
· delayed
Pre-market
Sep 2 '83
Mkt cap
$8.9M
Revenue
—
Revenue
—
vs
Compare
Pre-market
Sep 2 '83
GOSS
Gossamer Bio, Inc.
vs
INAB
IN8BIO, Inc.
10.35
pre 10.21
Price
0.94
pre 0.94
delayed
$63.4M
Mkt cap
$8.9M
Q2 FY26
$9M
Revenue
—
FY25
$48M
Revenue
—
Change
Change
GOSS
10.35
vs
INAB
0.94
Pre-market
Sep 2 '83